U.S. Dialysis Market Analysis

U.S. Dialysis Market Analysis

U.S. dialysis market share from the hemodialysis segment is expected to surpass USD 54.5 billion by 2032 as it assists in the mineral balancing of calcium, sodium, and potassium, which lowers blood pressure. An increase in the demand for hemodialysis is attributed to the growing number of kidney-related illnesses. Moreover, diabetic patients have a significant risk of having renal conditions that require dialysis at either an acute or chronic stage. According to CDC estimates for 2022, more than 37.3 million people, or 11.3% of the U.S. population, have diabetes and that number will likely rise in the coming years.
 

U.S. dialysis market share from the services segment is anticipated to cross USD 47.5 billion by 2032. The growing accessibility of dialysis at homes and clinics has led to an increase in demand for such services among the patient population. The need for medical supplies used during dialysis is expected to increase as many people opt for this therapy. Many manufacturers in the industry are focusing on creating cutting-edge dialysis equipment that will support the overall industry development.
 

U.S. dialysis market from the in-center dialysis segment is predicted to witness a 3.9% CAGR from 2023 to 2032. Patients operated across these centers have the benefit to relax and interact with other patients and staff, which enhances the effectiveness of their treatment and their general health. The availability of trained renal care professionals offering the best service possible is another factor contributing to the growing popularity of in-center dialysis therapy. Furthermore, the treatment and patient assessment is performed at the same location which increases its adoption, thus proving beneficial for segment value.
 

U.S. dialysis market from the South Atlantic zone is forecasted to reach around USD 13.4 billion by 2032 owing to the high prevalence of chronic diseases, rising per capita income, and aging population in the region. Georgia is home to a vast patient base with chronic renal disorders, which is anticipated to drive market expansion. As per CDC data, in 2021, more than 4% of adults in Georgia were detected with kidney diseases by healthcare professionals.
 

Several market participants ae looking to initiate number of programs to enhance the care of dialysis patients. For instance, in 2021, WellCare Georgia announced its plan to partner with Somatus Inc. to create a care program for patients suffering from end-stage renal disease and CKD. Such initiatives, which aim to aid renal disease patients, will promote the expansion of the industry.